Search results for: Maria Boratyńska

Items from 1 to 9 out of 9 results

article

Immune activation‐ and regulation‐related patterns in stable hand transplant recipients

Dorota Kamińska, Katarzyna Kościelska‐Kasprzak, Magdalena Krajewska, Adam Chełmoński, more

Transplant International > 30 > 2 > 144 - 152

We assessed cell subsets and expression of a set of genes related to the T‐cell populations in peripheral blood mononuclear cells to elucidate whether immune status of stable hand transplant recipients (HTx) differs from stable kidney transplant recipients (KTx). The study was conducted on five HTx 4.8 ± 1.7 years after transplantation and 30 stable KTx 7.9 ± 2.4 years after transplantation as well...

article

Transplantology: Challenges for Today

Maria Boratyńska, Dariusz Patrzałek

Archivum Immunologiae et Therapiae Experimentalis > 2016 > 64 > 1 > 37-45

Clinical transplantology in Poland had its 50th anniversary this year. With the early and long results comparable to the best achieved in the world leading centers, we face old and completely new challenges for this medical speciality. Main and growing challenge is insufficient number of available organs. With less than 15 donors/mln population/year Poland stay in the lower row of European countries...

article

The influence of non‐HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes

Mirosław Banasik, Maria Boratyńska, Katarzyna Kościelska‐Kasprzak, Dorota Kamińska, more

Transplant International > 27 > 10 > 1029 - 1038

Non‐HLA antibodies (Abs) targeting vascular receptors are thought to have an impact on renal transplant injury. Anti‐angiotensin II type 1‐receptor‐activating antibodies (anti‐AT1R) have been mentioned to stimulate a severe vascular rejection, but the pretransplant screening has not been introduced yet. The aim of our study was to assess the incidence and importance of anti‐AT1R antibodies and their...

article

Humoral immunity in hand transplantation: Anti-HLA and non-HLA response

Mirosław Banasik, Jerzy Jabłecki, Maria Boratyńska, Dorota Kamińska, more

Human Immunology > 2014 > 75 > 8 > 859-862

Antibodies against donor’s HLA antigens and B cell activity are recognized modulators of immune response to allograft. The role of both anti-HLA and non-HLA antibodies is understood in solid organ transplantation, but has not been addressed in composite tissue allografts.We decided to evaluate the presence and role of anti-HLA and non-HLA antibodies after hand transplantation.We assayed anti-HLA and...

article

Catatonic episode after kidney transplantation

Mariusz Kusztal, Patryk Piotrowski, Oktawia Mazanowska, Błażej Misiak, more

General Hospital Psychiatry > 2014 > 36 > 3 > 360.e3-360.e5

There is a growing body of case reports of catatonic symptoms after organ transplantations. A considerable number of these cases might be attributed to neurotoxicity induced by immunosuppressive medications. However, the etiology of other cases remains unclear. We present the case of a 21-year-old woman who developed catatonia after kidney transplantation from a deceased donor. In this case, nontoxic...

article

The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes

Mirosław Banasik, Maria Boratyńska, Katarzyna Kościelska-Kasprzak, Magdalena Krajewska, more

Transplant Immunology > 2014 > 30 > 1 > 24-29

Non-HLA antibodies (Abs) targeting vascular receptors are considered to have an influence on renal transplant injury. Anti-endothelin-1 type A receptor (anti-ETAR) antibodies were associated with cellular and antibody-mediated rejection and early onset of vasculopathy in heart transplant patients but their role in renal transplantation remains unclear. The aim of our study was to assess the incidence...

article

Odpowiedź na recenzję

Maria Boratyńska

Forum Prawnicze > 2013 > 2 (16) > 68-71

article

Reccurence of Kaposi's sarcoma after increased exposure to sirolimus

Maria Boratyńska, Sławomir C. Zmonarski, Marian Klinger

International Immunopharmacology > 2006 > 6 > 13-14 > 2018-2022

The conversion to sirolimus treatment is recently indicated as an effective therapy of Kaposi's sarcoma (KS) in transplant patients. We present two treatment modalities in patients with KS and recurrence of the disease after increasing sirolimus dose.Among 1034 renal transplants performed at our center, three (0.3%) suffered from KS. Initial immunosuppression consisted of cyclosporine, azathioprine...

article

Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression> in renal allograft recipients

Maria Boratynska, Tomasz Szepietowski, Zenon Szewczyk, Zygmunt Szydlowski

Archivum Immunologiae et Therapiae Experimentalis > 1992 > 40 > 2 > 163-168

In attempt to avoid a detrimental synergism between CsA and renal ischemia in the immediate postoperative perion, ALG (425 limphocytotxic units/kg) with small doses of CsA (6-8 mg/kg) and P were applied as the initial immunosuppressive therapy in 14 recipients of cadaveric kidneys. ALG was administered for 5 to 14 days and 2 days before withdrawing ALG, Aza (2 mg/kg) was intorduced. Results of this...

Filter options

Publication date

Set your own date range

INFONA - science communication portal

Search results for: Maria Boratyńska

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Content availability

Publication language

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options